Scinovex
review Open AccessTop 1% cited

Cancer Genome Landscapes

Science · 2013 · Vol. 339(6127) · pp. 1546–1558
Bert VogelsteinNickolas PapadopoulosVictor E. VelculescuShibin ZhouLuis A. DíazKenneth W. Kinzler

Abstract

Over the past decade, comprehensive sequencing efforts have revealed the genomic landscapes of common forms of human cancer. For most cancer types, this landscape consists of a small number of "mountains" (genes altered in a high percentage of tumors) and a much larger number of "hills" (genes altered infrequently). To date, these studies have revealed ~140 genes that, when altered by intragenic mutations, can promote or "drive" tumorigenesis. A typical tumor contains two to eight of these "driver gene" mutations; the remaining mutations are passengers that confer no selective growth advantage. Driver genes can be classified into 12 signaling pathways that regulate three core cellular processes: cell fate, cell survival, and genome maintenance. A better understanding of these pathways is one of the most pressing needs in basic cancer research. Even now, however, our knowledge of cancer genomes is sufficient to guide the development of more effective approaches for reducing cancer morbidity and mortality.

Cancer Genomics and DiagnosticsEpigenetics and DNA MethylationBioinformatics and Genomic NetworksGenomeGeneCarcinogenesisBiologyCancerGeneticsComputational biologyHuman genomeMutation

MeSH terms

Cell Transformation, NeoplasticHumansMutationNeoplasmsSignal TransductionGenome, HumanMutagenesisGenetic HeterogeneityGenes, Neoplasm

Funding

  • Lustgarten Foundation
  • Virginia and D.K. Ludwig Fund for Cancer Research
  • National Institutes of Health
Citations
7,937
FWCI
248.95
field-weighted impact
References
157
Percentile
100%
vs. same field & year
Citations per year
References
Epidermal growth factor receptor mutations in lung cancer
Nature reviews. Cancer · 2007 · 3,115 citations
ERBB receptors and cancer: the complexity of targeted inhibitors
Nature reviews. Cancer · 2005 · 3,292 citations
Fibroblast growth factor signalling: from development to cancer
Nature reviews. Cancer · 2010 · 2,644 citations
A genetic model for colorectal tumorigenesis
Cell · 1990 · 12,052 citations
CDK Inhibitors: Cell Cycle Regulators and Beyond
Developmental Cell · 2008 · 1,146 citations
Cell Signaling by Receptor Tyrosine Kinases
Cell · 2010 · 7,809 citations
The history of cancer epigenetics
Nature reviews. Cancer · 2004 · 2,348 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.